Kalled Musallam: A Comprehensive Review of Thalassemia
Kalled Musallam, Group Chief Research Officer at Burjeel Holdings and Deputy CEO and Chief of Cellular and Gene Therapy and Hematology at Burjeel Cancer Institute, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Nature Reviews Disease Primers, adding:
“Pleased to share our new comprehensive review on thalassemia published today in Nature Reviews Disease Primers, one of the leading journals from the Nature portfolio (impact factor 80), which will hopefully provide thalassemia with greater visibility across the broader scientific and medical community.”
Title: Thalassaemia
Authors: Frédéric B. Piel, Mariane de Montalembert, Reena Das, Kevin H. M. Kuo, Ali T. Taher, Khaled M. Musallam, Marsha Treadwell, Suthat Fucharoen, Michael Angastiniotis, Douglas Higgs, Elliott Vichinsky, Maria Domenica Cappellini, Lucia De Franceschi
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 31, 2026, 12:21Niksa Bagheri: Key Shear Regimes and Physics Selection for Continuum Thrombosis Modeling
-
Oct 31, 2026, 12:14Ghaith Abu-Zeinah: International MPN Congress Honors the Life and Legacy of MPN Pioneer Dr. Richard T. Silver
-
Oct 31, 2026, 12:11Thierry Burnouf: Taipei Medical University and University of Lille Highlight Platelet Biotherapies in SfN Neuronline
-
Oct 31, 2026, 12:07Eamon Faulkner: How Oxygen Shapes Platelet–Endothelial Interactions
-
Oct 31, 2026, 12:01Abdul Mannan: IVIG in ITP – When a Temporary Response Is a Success
-
Oct 31, 2026, 11:52Breaking the Silence Around Bleeding Disorders in Women – National Bleeding Disorders Foundation
-
Oct 31, 2026, 11:21Jim Meliezer: Aspirin May Help Prevent Recurrent Preterm Birth
-
Oct 31, 2026, 11:10Elly De Bruyn: QbD Group Quiz Supports the World Federation of Hemophilia
-
Oct 31, 2026, 11:04Abhivandan Nagia: The Expanding Clinical Pipeline in Hemophilia A